ACI’s 6th Annual Life Sciences IP Due Diligence Summit is devoted to providing corporate and IP counsel with expert strategies for assessing, valuing, and commercializing IP assets when.
Stocks Gain as Investors Wait for Inflation Data Wednesday s Labor Department report will inform the Fed s next decision on rates-and whether this year s market rally will continue.
.
October was a volatile month for the markets, and biotech stocks were no exception. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) had slipped about 17 percent in the period. This compares to S&P 500 s 7 percent retreat.
As we enter the last leg of the year, here are a few PDUFA. Read More.